AUA Updates BPH Treatment Guidelines, Expanding Options for Aging Male Patients

Event summary

  • The American Urological Association (AUA) released its 2026 Management of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign Prostatic Hyperplasia (BPH) Guideline on May 7, 2026.
  • The updated guideline includes 62 evidence-based recommendations, reflecting new clinical evidence and advances in medical and surgical treatments.
  • The guideline emphasizes shared decision-making and individualized care, recognizing multiple contributing factors beyond prostate enlargement.
  • The full guideline is available at AUANet.org/2026BPHGuideline, with summaries published in the Journal of Urology.

The big picture

The AUA's updated guideline comes as the aging male population in the U.S. grows, increasing demand for effective BPH treatments. The emphasis on shared decision-making aligns with broader trends in personalized medicine, while advances in minimally invasive procedures could reshape the competitive landscape for urological interventions. The guideline's release may also influence reimbursement policies and payer negotiations as new treatment protocols gain traction.

What we're watching

Adoption Pace
How quickly urologists integrate the updated recommendations into clinical practice, particularly for minimally invasive and surgical options.
Industry Impact
Whether the guideline accelerates innovation in BPH treatments, potentially benefiting medical device and pharmaceutical companies.
Patient Outcomes
The extent to which the individualized care approach improves quality of life for men with LUTS/BPH.